Implementation Research of Kangaroo Mother Care in Rural Pakistan.
Launched by AGA KHAN UNIVERSITY · Jun 1, 2018
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
An estimated 450,000 infant deaths can be prevented each year with the universal implementation of KMC at facility and community levels. The "Every Newborn Action Plan" endorsed and launched by the World Health Assembly in May 2014 includes the goal of scaling up KMC to 50% of babies weighing under 2000 grams by 2020, and to 75% of these babies by 2025(7).
Despite the availability of KMC as a cost-effective intervention its acceptance and uptake in Pakistan has been negligible. A situation analysis carried out by WHO of 12 countries in Asia and Africa to explore health system bottlenecks a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mother or family consents to participate in the trial.
- • All stable preterm small baby weighing (≥1200-\<2500 grams) are eligible for participating in the study. Mother's agreement to stay in health facility for 72 hours to implement KMC.
- Exclusion Criteria:
- • Well small baby; less than 1200 grams and baby more than 2500 grams will be excluded.
- • Babies presenting with danger signs and congenital malformation will be excluded and referred to advance care facility.
About Aga Khan University
Aga Khan University (AKU) is a distinguished institution dedicated to improving health and education across developing regions. Established in 1983, AKU is recognized for its commitment to research excellence, particularly in clinical trials that address pressing health issues in diverse populations. With a focus on advancing medical knowledge and practice, AKU's clinical trial initiatives are designed to foster innovative solutions and enhance patient care. The university collaborates with various local and international partners, leveraging its multidisciplinary expertise to conduct rigorous research that informs public health policy and improves health outcomes in communities served by its facilities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dadu, Sindh, Pakistan
Dadu, Sindh, Pakistan
Patients applied
Trial Officials
Zulfiqar A Bhutta, FCPS, PhD
Study Chair
Aga Khan University and Hospital
Dr Sajid B Soofi, MBBS, FCPS
Study Director
Aga Khan University
Dr Shabina Ariff, MBBS, FCPS
Principal Investigator
Aga Khan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials